Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Reed, MD
Cellerant Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Diego Moores Cancer Center
La Jolla, California, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- University of California, San Francisco Medical Center
San Francisco, California, United States
- Uf Health Shands Cancer Hospital
Gainesville, Florida, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northwestern Medical Faculty Foundation
Chicago, Illinois, United States
- the University of Chicago
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Indiana Blood and Marrow Transplantation Clinic
Indianapolis, Indiana, United States
- University of Massachusetts Worcester
Worcester, Massachusetts, United States
- University of Minnesota Physicians Bmt Clinic
Minneapolis, Minnesota, United States
- Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, United States
- Westchester Medical Center
Valhalla, New York, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- West Penn Hospital
Pittsburgh, Pennsylvania, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 22 Sept 2017
- Completion
- 22 Sept 2017
- Last update posted
- 27 Sept 2018
- Registered enrollment
- 163
- Registry id
- NCT02282215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.